BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 30789359)

  • 1. Undifferentiated Uterine Sarcomas Represent Under-Recognized High-grade Endometrial Stromal Sarcomas.
    Cotzia P; Benayed R; Mullaney K; Oliva E; Felix A; Ferreira J; Soslow RA; Antonescu CR; Ladanyi M; Chiang S
    Am J Surg Pathol; 2019 May; 43(5):662-669. PubMed ID: 30789359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCOR is a robust diagnostic immunohistochemical marker of genetically diverse high-grade endometrial stromal sarcoma, including tumors exhibiting variant morphology.
    Chiang S; Lee CH; Stewart CJR; Oliva E; Hoang LN; Ali RH; Hensley ML; Arias-Stella JA; Frosina D; Jungbluth AA; Benayed R; Ladanyi M; Hameed M; Wang L; Kao YC; Antonescu CR; Soslow RA
    Mod Pathol; 2017 Sep; 30(9):1251-1261. PubMed ID: 28621321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-grade Endometrial Stromal Sarcoma: Morphologic and Clinical Features, the Role of Immunohistochemistry and Fluorescence in Situ Hybridization in Diagnosis.
    Alkanat NE; Uner A; Usubutun A
    Int J Surg Pathol; 2023 Aug; 31(5):521-531. PubMed ID: 35506912
    [No Abstract]   [Full Text] [Related]  

  • 4. Uterine Endometrial Stromal Tumors With Pure Low-Grade Morphology Harboring YWHAE::NUTM2 Fusions: Report of a Case Series Emphasizing Potential for High-Grade Transformation and Aggressive Behavior.
    Devins KM; Attygalle AD; Croce S; Vroobel K; Oliva E; McCluggage WG
    Am J Surg Pathol; 2023 Jun; 47(6):717-724. PubMed ID: 37032555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-grade endometrial stromal sarcoma displaying immunohistochemical expression of BCOR-A report of two cases of a novel tumor entity.
    Wagh V; Menon S; Maheshwari A; Gupta S; Deodhar KK; Rekhi B
    Indian J Pathol Microbiol; 2023; 66(4):829-833. PubMed ID: 38084541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast metastasis in high-grade endometrial stromal sarcoma (HG-ESS) with BCOR rearrangement: a case report of a novel metastatic site.
    Fong A; Offman S
    Diagn Pathol; 2023 Mar; 18(1):34. PubMed ID: 36864468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-Grade Endometrial Stromal Sarcomas With YWHAE::NUTM2 Gene Fusion Exhibit Recurrent CDKN2A Alterations and Absence of p16 Staining is a Poor Prognostic Marker.
    Kommoss FKF; Mar LM; Howitt BE; Hanley K; Turashvilli G; Buslei R; Irving JA; Dickson BC; Koelsche C; Sinn HP; Schirmacher P; von Deimling A; Chiang S; McCluggage WG; Croce S; Stewart CJR; Lee CH
    Mod Pathol; 2023 Mar; 36(3):100044. PubMed ID: 36788095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and prognostic factors of endometrial stromal sarcoma and undifferentiated uterine sarcoma confirmed by central pathologic review: A multi-institutional retrospective study from the Japanese Clinical Oncology Group.
    Kikuchi A; Yoshida H; Tsuda H; Nishio S; Suzuki S; Takehara K; Kino N; Sumi T; Kato K; Yokoyama M; Nakamura K; Takano M; Sato S; Kato H; Tamate M; Horie K; Kato T; Sakamoto A; Fukunaga M; Kaku T; Yoshida M; Yaegashi N; Satoh T
    Gynecol Oncol; 2023 Sep; 176():82-89. PubMed ID: 37478616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uterine sarcomas and rare uterine mesenchymal tumors with malignant potential. Diagnostic guidelines of the French Sarcoma Group and the Rare Gynecological Tumors Group.
    Croce S; Devouassoux-Shisheboran M; Pautier P; Ray-Coquard I; Treilleux I; Neuville A; Arnould L; Just PA; Belda MALF; Averous G; Leroux A; Mery E; Loussouarn D; Weinbreck N; Le Guellec S; Mishellany F; Morice P; Guyon F; Genestie C
    Gynecol Oncol; 2022 Nov; 167(2):373-389. PubMed ID: 36114030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KDM2B-Rearranged Soft Tissue Sarcomas Expand the Concept of BCOR-Associated Sarcoma.
    Motoi T; Hirata M; Kukita Y; Satomi K; Tamura H; Adachi S; Matsushita Y; Horiguchi SI; Hishima T; Ikegami M; Okuma T; Tao K; Arakawa A; Ogawa C; Matsuda K; Ichimura K; Nakamura H; Mori T; Yoshida A
    Mod Pathol; 2023 Nov; 36(11):100317. PubMed ID: 37634866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on Uterine Mesenchymal Neoplasms.
    Kertowidjojo EC; Bennett JA
    Surg Pathol Clin; 2022 Jun; 15(2):315-340. PubMed ID: 35715164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ZC3H7B-BCOR Fusion High-grade Endometrial Stromal Sarcoma With Morphologic Features of Low-grade Endometrial Stromal Sarcoma. A Case Report and Review of Literature.
    Zhao L; Cheng YW; Policarpio-Nicolas MLC
    Int J Gynecol Pathol; 2023 Nov; 42(6):597-601. PubMed ID: 37562066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Unusual Endometrial Stromal Neoplasm With JAZF1-BCORL1 Rearrangement.
    Moghaddam PA; Young RH; Ismiil ND; Bennett JA; Oliva E
    Int J Gynecol Pathol; 2024 Jan; 43(1):33-40. PubMed ID: 36811828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent KAT6B/A::KANSL1 Fusions Characterize a Potentially Aggressive Uterine Sarcoma Morphologically Overlapping With Low-grade Endometrial Stromal Sarcoma.
    Agaimy A; Clarke BA; Kolin DL; Lee CH; Lee JC; McCluggage WG; Pöschke P; Stoehr R; Swanson D; Turashvili G; Beckmann MW; Hartmann A; Antonescu CR; Dickson BC
    Am J Surg Pathol; 2022 Sep; 46(9):1298-1308. PubMed ID: 35575789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Unusual Benign Uterine Stromal Spindle Cell Tumor Harboring JAZF1::BCORL1.
    Rodriguez Pena MDC; Mubeen A; Harada S; Prieto Granada CN
    Int J Gynecol Pathol; 2023 May; 42(3):319-324. PubMed ID: 35838627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LG-ESSs and HG-ESSs: underlying molecular alterations and potential therapeutic strategies.
    Li C; Wang C
    J Zhejiang Univ Sci B; 2021 Aug; 22(8):633-646. PubMed ID: 34414699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pan-TRK immunohistochemistry in gynaecological mesenchymal tumours: diagnostic implications and pitfalls.
    Moura MS; Costa J; Velasco V; Kommoss F; Oliva E; Le Loarer F; McCluggage WG; Razack R; Treilleux I; Mills A; Longacre T; Devouassoux-Shisheboran M; Hostein I; Azmani R; Blanchard L; Hartog C; Soubeyran I; Khalifa E; Croce S
    Histopathology; 2024 Feb; 84(3):451-462. PubMed ID: 37988282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic and Transcriptomic Characterization Revealed the High Sensitivity of Targeted Therapy and Immunotherapy in a Subset of Endometrial Stromal Sarcoma.
    Kang N; Zhang Y; Guo S; Chen R; Kong F; Wang S; Yuan M; Chen R; Shen D; Wang J
    Cancer Res Treat; 2023 Jul; 55(3):978-991. PubMed ID: 36731460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NCOA1/2/3 rearrangements in uterine tumor resembling ovarian sex cord tumor: A clinicopathological and molecular study of 18 cases.
    Lu B; Xia Y; Chen J; Tang J; Shao Y; Yu W
    Hum Pathol; 2023 May; 135():65-75. PubMed ID: 36646185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The utility of FISH analysis in the diagnosis of BCOR-rearranged sarcomas.
    Cocchi S; Gambarotti M; Gamberi G; Magagnoli G; Maioli M; Stevanin M; Samperi F; Righi A; Benini S
    Pathol Res Pract; 2024 Mar; 255():155209. PubMed ID: 38422910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.